Home » Hemophilia therapies account for largest portion of pharmacy expenditures among publicly insured children with serious chronic illness

Hemophilia therapies account for largest portion of pharmacy expenditures among publicly insured children with serious chronic illness

In an analysis of expenditures for outpatient pharmacy products used by publicly insured children with serious chronic illness in California, treating hemophilia accounted for about 40 percent of…

By | 2015-07-28T16:00:00+00:00 July 28th, 2015|Health Insurance / Medical Insurance|Comments Off on Hemophilia therapies account for largest portion of pharmacy expenditures among publicly insured children with serious chronic illness